Glenmark bags FDA approval for new generic

Glenmark Pharmaceuticals receives final ANDA approval for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/1 mg per gram and tentative ANDA approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg

id-10039602-1

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/1 mg per gram, the generic version of Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/1 mg per gram of Taro.

Glenmark Pharmaceuticals Inc., USA (Glenmark) has also been granted tentative approval by the United States Food & Drug Administration (US FDA) for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, the generic version of Benicar Tablets of Daiichi Sankyo, Inc

 

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X